RT Journal Article
SR Electronic
T1 SIR-PID: A Proportional-Integral-Derivative Controller for COVID-19 Outbreak Containment
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.30.20117556
DO 10.1101/2020.05.30.20117556
A1 Ianni, Aldo
A1 Rossi, Nicola
YR 2020
UL http://medrxiv.org/content/early/2020/06/03/2020.05.30.20117556.abstract
AB Ongoing social restrictions, as distancing and lockdown, adopted by many countries for contrasting the COVID-19 epidemic spread, try to find a trade-off between induced economic crisis, healthcare system collapse and costs in terms of human lives. Applying and removing restrictions on a system with uncontrollable inertia, as represented by an epidemic outbreak, may create critical instabilities, overshoots and strong oscillations of infected people around the desirable set-point, defined as the maximum number of hospitalizations acceptable by a given healthcare system. A good understanding of the system reaction to a change of the input control variable can be reasonably achieved using a proportional-integral-derivative controller, widely used in technological applications. In this paper we make use of this basic control theory for understanding the reaction of COVID-19 propagation to social restrictions and for exploiting a very known technology to reduce the epidemic damages through the correct tuning of the containment policy.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.worldometers.info/coronavirus/ Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB/oversight is not needed for this paperAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeshttps://www.worldometers.info/coronavirus/ https://www.worldometers.info/coronavirus/